The South West Area Mesothelioma and Pemetrexed trial: a multicentre prospective observational study evaluating novel markers of chemotherapy response and prognostication

BACKGROUND: Robust markers that predict prognosis and detect early treatment response in malignant pleural mesothelioma (MPM) would enhance patient care. METHODS: Consecutive patients with MPM who were considered fit for first-line chemotherapy were prospectively recruited. Patients of similar perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooper, C E, Lyburn, I D, Searle, J, Darby, M, Hall, T, Hall, D, Morley, A, White, P, Rahman, N M, De Winton, E, Clive, A, Masani, V, Arnold, D T, Dangoor, A, Guglani, S, Jankowska, P, Lowndes, S A, Harvey, J E, Braybrooke, J P, Maskell, N A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385956/
https://www.ncbi.nlm.nih.gov/pubmed/25756396
http://dx.doi.org/10.1038/bjc.2015.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385956/
https://www.ncbi.nlm.nih.gov/pubmed/25756396
http://dx.doi.org/10.1038/bjc.2015.62

Ejemplares similares